GUY A WEISS

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology BUFFALO, NY NPI 1598084030

General Payments — all program years on this page

$7,717.59

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,706.04 across 29 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $6,570.8626
Food and Beverage $135.183

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $500.001
2023 $511.554
2024 $6,706.0429

Records — PY2024 (29)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078413923 Janssen Biotech, Inc. $103.03 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114406542 Regeneron Pharmaceuticals, Inc. $13.91 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114406544 Regeneron Pharmaceuticals, Inc. $2,094.00 09/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114406546 Regeneron Pharmaceuticals, Inc. $872.50 09/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114406548 Regeneron Pharmaceuticals, Inc. $349.00 09/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114406550 Regeneron Pharmaceuticals, Inc. $523.50 09/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696272 Takeda Pharmaceuticals U.S.A., Inc. $411.18 10/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696274 Takeda Pharmaceuticals U.S.A., Inc. $288.98 10/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696276 Takeda Pharmaceuticals U.S.A., Inc. $35.00 10/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696278 Takeda Pharmaceuticals U.S.A., Inc. $548.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696280 Takeda Pharmaceuticals U.S.A., Inc. $26.89 10/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696282 Takeda Pharmaceuticals U.S.A., Inc. $225.80 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696284 Takeda Pharmaceuticals U.S.A., Inc. $139.28 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696286 Takeda Pharmaceuticals U.S.A., Inc. $197.38 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696288 Takeda Pharmaceuticals U.S.A., Inc. $197.38 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696290 Takeda Pharmaceuticals U.S.A., Inc. $122.54 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696292 Takeda Pharmaceuticals U.S.A., Inc. $33.97 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696294 Takeda Pharmaceuticals U.S.A., Inc. $19.65 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696296 Takeda Pharmaceuticals U.S.A., Inc. $48.95 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696298 Takeda Pharmaceuticals U.S.A., Inc. $19.65 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696300 Takeda Pharmaceuticals U.S.A., Inc. $122.54 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696302 Takeda Pharmaceuticals U.S.A., Inc. $33.97 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696304 Takeda Pharmaceuticals U.S.A., Inc. $19.65 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696306 Takeda Pharmaceuticals U.S.A., Inc. $48.98 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696308 Takeda Pharmaceuticals U.S.A., Inc. $73.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696310 Takeda Pharmaceuticals U.S.A., Inc. $39.97 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696312 Takeda Pharmaceuticals U.S.A., Inc. $55.00 11/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137696314 Takeda Pharmaceuticals U.S.A., Inc. $24.10 11/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1154320696 Laborie Medical Technologies Corp. $18.24 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.